Published in Br J Cancer on April 01, 1985
The international variation in breast cancer rates: an epidemiological assessment. Breast Cancer Res Treat (1991) 1.16
A prospective study of urinary oestrogen excretion and breast cancer risk. Br J Cancer (1996) 1.14
A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer. Environ Health Perspect (1997) 1.10
Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls. Br J Cancer (1990) 1.05
Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res (2005) 0.95
Endogenous estrogens and breast cancer risk: the case for prospective cohort studies. Environ Health Perspect (1997) 0.92
Serum oestradiol in women with and without breast disease. Br J Cancer (1990) 0.81
Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr (1974) 16.83
New automated dye-binding method for serum albumin determination with bromcresol purple. Clin Chem (1978) 1.52
Serum sex hormone-binding globulin capacity and the percentage of free estradiol in postmenopausal women with and without endometrial carcinoma. A new biochemical basis for the association between obesity and endometrial carcinoma. Am J Obstet Gynecol (1980) 1.19
Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease. Cancer Res (1983) 1.12
Estimation of the percentage of free steroid in undiluted serum by centrifugal ultrafiltration-dialysis. J Biol Chem (1980) 1.11
Abnormal sex steroid secretion and binding in massively obese women. Clin Endocrinol (Oxf) (1980) 1.09
Plasma oestradiol and progesterone levels in women with varying degrees of risk of breast cancer. Eur J Cancer (1978) 0.94
Measurement of the testosterone binding parameters for both testosterone-estradiol binding globulin and albumin in individual serum samples. Steroids (1979) 0.90
Gene interaction and single gene effects in colon tumour susceptibility in mice. Nat Genet (1996) 2.84
Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer (1999) 2.68
Recombinant congenic strains--a new tool for analyzing genetic traits determined by more than one gene. Immunogenetics (1986) 2.28
Prothrombal: a new concentrate of human prothrombin complex for clinical use. Br J Haematol (1971) 2.25
Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology (1999) 2.24
Pulmonary resection for metastases of colorectal origin. Chest (1995) 2.09
Serum insulin-like growth factor-I and breast cancer. Int J Cancer (2000) 1.82
Prognostic factors of neck node metastasis. Clin Otolaryngol Allied Sci (1982) 1.67
Response of leptomeningeal metastases from breast cancer to hormonal therapy. Neurology (2000) 1.60
The impact of treatment time and smoking on local control and complications in T1 glottic cancer. Int J Radiat Oncol Biol Phys (1998) 1.57
Insulin resistance and breast-cancer risk. Int J Cancer (1992) 1.57
Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment. Cancer (1991) 1.56
Positive iliac and obturator nodes in melanoma: survival and prognostic factors. Ann Surg Oncol (1999) 1.55
Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med (1993) 1.55
The interpretation of multiple P-values. Radiother Oncol (1994) 1.54
Lymph node metastasis from melanoma with an unknown primary site. Br J Surg (1990) 1.49
Dietary habits, sexual maturation, and plasma hormones in pubertal girls: a longitudinal study. Am J Clin Nutr (1991) 1.49
Clear cell sarcoma (malignant melanoma) of soft parts: A clinicopathologic study of 30 cases. Cancer (1999) 1.46
Body fat mass, body fat distribution, and pubertal development: a longitudinal study of physical and hormonal sexual maturation of girls. J Clin Endocrinol Metab (1992) 1.44
The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach. Ann Oncol (1993) 1.42
Detection of systematic patient setup errors by portal film analysis. Radiother Oncol (1992) 1.41
Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin. Cancer Treat Rep (1984) 1.25
Resectable retroperitoneal soft tissue sarcomas. The effect of extent of resection and postoperative radiation therapy on local tumor control. Cancer (1994) 1.25
Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome. J Natl Cancer Inst (2001) 1.24
Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan. Surgery (1994) 1.23
Systematic approach to the treatment of chylous leakage after neck dissection. Head Neck (1996) 1.22
Some prognostic and epidemiologic factors in canine osteosarcoma. J Natl Cancer Inst (1979) 1.21
Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. Am J Epidemiol (1997) 1.20
Body fat distribution and obesity in pre- and postmenopausal breast cancer. Int J Epidemiol (1999) 1.19
Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg (1997) 1.18
Brain metastases in breast cancer; natural history, prognostic factors and outcome. J Neurooncol (1993) 1.18
Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes. Genes Immun (2000) 1.12
The development of a prognostic score for patients with parotid carcinoma. Cancer (1999) 1.11
MAM-6 antigen, a new serum marker for breast cancer monitoring. Cancer Res (1986) 1.11
Determination of benzo[a]pyrene diol epoxide-DNA adducts in white blood cell DNA from coke-oven workers: the impact of smoking. J Natl Cancer Inst (1990) 1.11
Marfan syndrome in children and adolescents: predictive and prognostic value of aortic root growth for screening for aortic complications. Heart (1998) 1.10
Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours. J Neurol Neurosurg Psychiatry (1987) 1.10
Tamoxifen, serum lipoproteins and cardiovascular risk. Br J Cancer (1988) 1.08
The H-reflex of the flexor carpi radialis muscle; a study in controls and radiation-induced brachial plexus lesions. J Neurol Neurosurg Psychiatry (1984) 1.08
Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes. Cancer (2000) 1.07
Marfan syndrome in children and adolescents: an adjusted nomogram for screening aortic root dilatation. Heart (1998) 1.07
Stage as major long term outcome predictor in minor salivary gland carcinoma. Cancer (2000) 1.07
Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int J Cancer (1995) 1.06
The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Radiother Oncol (1999) 1.05
Glucocorticoid receptor in cultured human skin fibroblasts. J Steroid Biochem (1979) 1.05
Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma. Neurology (1983) 1.05
Body fat mass, body fat distribution, and plasma hormones in early puberty in females. J Clin Endocrinol Metab (1990) 1.04
Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration. Eur J Cancer Clin Oncol (1983) 1.04
Scc-1, a novel colon cancer susceptibility gene in the mouse: linkage to CD44 (Ly-24, Pgp-1) on chromosome 2. Oncogene (1992) 1.04
The prevalence of mental health problems in Rwandan and Burundese refugee camps. Acta Psychiatr Scand (2000) 1.02
Non-Hodgkin's lymphomata: clinical features in relation to histology. Br J Cancer Suppl (1975) 1.01
Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease. J Clin Oncol (1989) 1.01
Identification of high-risk groups among node-positive patients with stage IB and IIA cervical carcinoma. Gynecol Oncol (1997) 0.99
The quality of life of long-term survivors of Hodgkin's disease. Ann Oncol (1994) 0.97
Cerebrospinal fluid beta-glucuronidase activities in patients with central nervous system metastases. Clin Chim Acta (1985) 0.97
Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer. Proc Natl Acad Sci U S A (1996) 0.97
Body measurements, estrogen availability and the risk of human breast cancer: a case-control study. Int J Cancer (1992) 0.97
Reliability of serum prolactin measurements in women. Cancer Epidemiol Biomarkers Prev (1993) 0.97
Treatment results of primary stage I and II non-Hodgkin's lymphoma of the stomach. Radiother Oncol (1988) 0.96
Quantification of patient to patient variation of skin erythema developing as a response to radiotherapy. Radiother Oncol (1994) 0.95
Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2. Cancer Res (1995) 0.95
Spread according to histology in non-Hodgkin's lymphomata. Br J Cancer Suppl (1975) 0.95
Radio-immuno assay of lactoferrin in blood plasma of breast cancer patients, lactating and normal women; prevention of false high levels caused by leakage from neutrophile leucocytes in vitro. Folia Med Neerl (1972) 0.95
Prognostic factors in canine mammary cancer. J Natl Cancer Inst (1976) 0.95
The influence of age on treatment choice and survival of elderly breast cancer patients in south-eastern Netherlands: a population-based study. Eur J Cancer (1992) 0.95
Outcome of thoracoscopic pulmonary metastasectomy evaluated by confirmatory thoracotomy. Ann Thorac Surg (2001) 0.95
A retrospective study of male breast cancer in Holland. Br J Surg (1985) 0.94
Value of resection of pulmonary metastases in head and neck cancer patients. Head Neck (1996) 0.94
Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist. Eur J Cancer (2000) 0.93
Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancer. Gynecol Oncol (1994) 0.93
Provider-associated factors in obstetric interventions. Eur J Obstet Gynecol Reprod Biol (1995) 0.93
The prognostic significance of a previous malignancy in operable non-small cell lung cancer. Lung Cancer (2001) 0.93
Circadian rhythms in systemic hemodynamics and renal function in healthy subjects and patients with nephrotic syndrome. Kidney Int (2001) 0.93
Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control. Int J Radiat Oncol Biol Phys (1998) 0.93
The recombinant congenic strains--a novel genetic tool applied to the study of colon tumor development in the mouse. Mamm Genome (1991) 0.91
Influence of mouse major histocompatibility complex (H-2) on N-ethyl-N-nitrosourea-induced tumor formation in various organs. Cancer Res (1988) 0.91
Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome. Leukemia (1999) 0.91
Cerebrospinal fluid carcinoembryonic antigen in patients with metastatic and nonmetastatic neurological diseases. Arch Neurol (1986) 0.91
Pharmacokinetics of melphalan in isolated perfusion of the limbs. J Pharmacol Exp Ther (1986) 0.91
Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53. Radiother Oncol (2001) 0.91
Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients. Cancer Res (1988) 0.91
Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes. Cancer (1997) 0.91
Splenectomy in Hodgkin's disease and second leukaemias. Lancet (1987) 0.91
Treatment of haemophilia B with purified Factor IX (PPSB). Folia Med Neerl (1967) 0.91
Prognostic factors in feline mammary carcinoma. J Natl Cancer Inst (1983) 0.90
The Bax alpha:Bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukaemia. Int J Cancer (1997) 0.90
Preoperative and operative factors associated with pain after the first endodontic visit. Int Endod J (1987) 0.90
Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer. Int J Radiat Biol (1998) 0.90
Persisting Haemophilus influenzae strains induce lower levels of interleukin-6 and interleukin-8 in H292 lung epithelial cells than nonpersisting strains. Eur Respir J (1997) 0.90
Identification and biopsy of the sentinel lymph node in breast cancer. Eur J Surg Oncol (1998) 0.90
Survival of adult patients with head and neck soft tissue sarcomas. Clin Otolaryngol Allied Sci (1996) 0.89
Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study. AIDS (2000) 0.89
Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer. Cancer (1995) 0.88
Limb-sparing therapy of extremity soft tissue sarcomas: treatment outcome and long-term functional results. Eur J Cancer (1994) 0.88